Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Growth hormone (GH) is an essential element for normal growth. However, reports of normal growth without GH have been made in patients who have undergone brain surgery for craniopharyngioma. Normal growth without GH can be explained by hyperinsulinemia, hyperprolactinemia, elevated leptin levels, and GH variants; however, its exact mechanism has not been elucidated yet. We diagnosed a female patient aged 13 with combined pituitary hormone deficiency (CPHD) caused by pituitary stalk interruption syndrome (PSIS). The patient has experienced recurrent hypoglycemic seizures since birth, but reached the height of 160 cm at the age of 13, showing normal growth. She grew another 8 cm for 3 years after the diagnosis, and she reached her final adult height of 168 cm which was greater than the midparental height, at the age of 16. The patient’s blood GH and insulin-like growth factor-I levels were consistently subnormal, although her insulin levels were normal. Her physical examination conducted at the age of 15 showed truncal obesity, dyslipidemia, and osteoporosis, which are metabolic features of GH deficiency (GHD). Herein, we report a case in which a PSIS-induced CPHD patient attained her final height above mid parental height despite a severe GHD.
Abstract
Growth hormone (GH) is an essential element for normal growth. However, reports of normal growth without GH have been made in patients who have undergone brain surgery for craniopharyngioma. Normal growth without GH can be explained by hyperinsulinemia, hyperprolactinemia, elevated leptin levels, and GH variants; however, its exact mechanism has not been elucidated yet. We diagnosed a female patient aged 13 with combined pituitary hormone deficiency (CPHD) caused by pituitary stalk interruption syndrome (PSIS). The patient has experienced recurrent hypoglycemic seizures since birth, but reached the height of 160 cm at the age of 13, showing normal growth. She grew another 8 cm for 3 years after the diagnosis, and she reached her final adult height of 168 cm which was greater than the midparental height, at the age of 16. The patient’s blood GH and insulin-like growth factor-I levels were consistently subnormal, although her insulin levels were normal. Her physical examination conducted at the age of 15 showed truncal obesity, dyslipidemia, and osteoporosis, which are metabolic features of GH deficiency (GHD). Herein, we report a case in which a PSIS-induced CPHD patient attained her final height above mid parental height despite a severe GHD.
참고문헌 (14)
- Lazar L, "Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary hormone deficiency", Clin Endocrinol (Oxf), 59, pp.82~88 (2003)
- David WC, "Williams textbook of endocrinology", pp.964~1073 (2016), Elsevier Saunders
- Geffner ME, "The growth without growth hormone syndrome", Endocrinol Metab Clin North Am, 25, pp.649~663 (1996)
- Matson DD, "Craniopharyngioma", Clin Neurosurg, 10, pp.116~129 (1962)
- Holmes LB, "Normal growth with subnormal growth-hormone levels", N Engl J Med, 279, pp.559~566 (1968)
- Costin G, "Hypothalamic-pituitary function in children with optic nerve hypoplasia", Am J Dis Child, 139, pp.249~254 (1985)
- Geffner ME, "Growth without growth hormone: evidence for a potent circulating growth factor", Lancet, 1, pp.343~347 (1986)
- Murashita M, "Near-normal linear growth in the setting of markedly reduced growth hormone and IGF-1. A case report", Horm Res, 51, pp.184~188 (1999)
- Bucher H, "Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma", N Engl J Med, 309, pp.1142~1146 (1983)
- Holloway WR, "Leptin inhibits osteoclast generation", J Bone Miner Res, 17, pp.200~209 (2002)
- Hathout EH, "Normal growth despite GH, IGF-I and IGF-II deficiency", Growth Horm IGF Res, 9, pp.272~277 (1999)
- Arroyo A, "A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty", Clin Endocrinol (Oxf), 57, pp.283~291 (2002)
- Pavlou M, "A study of the growth-promoting and metabolic effects of growth hormone (GH) in a patient with the "growth without GH" syndrome", Growth Horm IGF Res, 11, pp.225~230 (2001)
- Csizmadi I, "Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects", Metabolism, 38, pp.1016~1021 (1989)